With more than $121 million in international ticket sales entering the Columbus Day weekend, MGM/United Artists Releasing’s domestic debut of the 25th James Bond movie, No Time to Die, is projected to be a runaway winner at the box office through Oct. 10-11.
The movie, which has seen its release delayed four times due to the pandemic, has more than the usual buzz surrounding a Bond movie. In addition to a Grammy-winning theme song from Billie Eilish, and a 4,400-screen launch, No Time represents actor Daniel Craig’s fifth and final turn as Agent 007, a role he singularly rebooted into his own (including blond hair) — with smashing success.
Craig’s previous Bond roles in Casino Royale, Quantum of Solace, Skyfall and Spectre generated a collective $3.2 billion in global ticket sales.
Interestingly, Craig’s No Time co-star, Ana de Armas, stole the show (and award nominations) in Craig’s biggest non-Bond movie, Knives Out, which generated more than $311 million at the box office.
Assisting Bond over Columbus Day is the reality that big tentpole movies are again resonating with COVID-leery moviegoers. Following the September domination of Disney/Marvel’s Shang-Chi and the Legend of the Ten Rings, Sony Pictures sequel Venom: Let There Be Carnage, shattered expectations with a $90 million box office debut Oct. 1-3.
In addition, online ticket platform Fandango reportedly has pre-sold more tickets for No Time than Let There Be Carnage and Universal Pictures’ F9: The Fast Saga. With the hype, industry scuttlebutt suggests No Time could become the first Bond movie to crack $100 million in its opening weekend. Skyfall remains the biggest Bond opener with $88.4 million through Nov. 9-11, 2012.
Meanwhile, Let There Be Carnage is projected to generate upwards of $28 million in its second weekend at theaters, with MGM/United Artists Releasing’s The Addams Family 2 selling another $10 million in domestic tickets.